Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV CongressSeptember 16, 2026
Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in ItalySeptember 15, 2026
Technology China unveils AI protein synthesis platform in ShanghaiJuly 11, 2026 SHANGHAI / RankWire.AI / – Chinese researchers have unveiled an AI-assisted platform that converts computer-designed protein sequences into physical samples…
